Zhongnan Medical Journal Press

Home Results

A total of 11 result was found. Results that relate to Hepatocellular carcinoma

Analysis of the expression of TMEM88 in hepatocytes and its relationship with prognosis based on TCGA and other databases

Published on Journal of Mathematical Medicine 2023,36(4):267-281.
4438 times 1060 times

Andrew Liman Qian ZHU

Bioinformatic Transmembrane protein 88 Hepatocellular Carcinoma
Details
Current perspectives on tertiary lymphoid structures and PD-1/PD-L1 signaling pathway in the immunotherapy of hepatocellular carcinoma

Published on New Medicine 2023,33(5):373-380.
4030 times 1266 times

Hao-Dong QIAO Yi-Fan LIU Ze LIANG Huai-Bin GUO

Hepatocellular carcinoma Immunotherapy PD-1/PD-L1 signaling pathway Tertiary lymphoid structures
Details
Cost-utility analysis of tislelizumab versus sorafenib as first-line treatment for advanced unresectable hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):109-116.
3116 times 941 times

SU Zhan CHE Jinhui PEI Ruifeng

Hepatocellular carcinoma Tislelizumab Sorafenib Partition survival model Pharmacoeconomic analysis
Details
Real-world study of sintilimab combined with bevacizumab in patients with advanced hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):485-490.
3965 times 1219 times

SU Zhan CHE Jinhui PEI Ruifeng

Advanced hepatocellular carcinoma Sintilimab Bevacizumab Clinical efficacy Safety Overall survival Progression-free survival
Details
Efficacy and safety of tislelizumab combined with sorafenib in the treatment for unresectable hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(8):1136-1342.
4152 times 750 times

JIANG Jinghua HU Yiting

Tirilizumab Sorafenib Unresectable Hepatocellular carcinoma Objective response rate Disease control rate Progression-free survival Overall survival
Details
Causal association between systemic inflammatory factors and the risk of hepatocellular carcinoma based on Mendelian randomization

Published on Journal of Mathematical Medicine 2024,37(8):592-599.
6896 times 951 times

LI Xinyu NIE Duorui XIAO Tingfen CAO Jun WANG Zhiqi XU Fei CHEN Chang

Inflammatory factors Hepatocellular carcinoma Mendelian randomization analysis GWAS
Details
Exploring the medication rules of hepatic precancerous lesions based on data mining

Published on Frontiers in Pharmaceutical Sciences 2024,28(1):80-89.
4404 times 661 times

GOU Siyuan YANG Xianzhao WANG Longzhu TIAN Yujia RU Shuying

Hepatocellular carcinoma Precancerous lesions Traditional Chinese medicine Data mining Medication rule Milkvetch root Largehead atractylodes rhizome Radix salviae miltiorrhhizae
Details
Analysis and prediction model construction of infection after transcatheter arterial chemoembolization in hepatocellular carcinoma patients

Published on New Medicine 2024,34(12):1345-1356.
2795 times 644 times

DU Jiao DA Xiuwei ZHANG Qing YAN Yan LIU Dan GAO Nan GAO Min ZHANG Hongxin WANG Miaomiao

Hepatocellular carcinoma Transcatheter arterial chemoembolization Pathogenic bacteria Infection Prediction model
Details
Mendelian randomization and bioinformatics analysis of TRIM31 with chronic liver disease

Published on New Medicine 2025,35(3):303-311.
1794 times 583 times

YOU Junyi LIANG Guoqiang SONG Xiudao

Mendelian randomization Tripartite motif 31 Chronic liver disease Hepatocellular carcinoma Bioinformatics
Details
Study of the correlation between PTTG1 gene expression and hepatocellular carcinoma based on integrative bioinformatics

Published on Journal of Mathematical Medicine 2025,38(7):518-526.
698 times 100 times

ZOU Yuhui DUAN Hui WU Jingchun SU Qian

PTTG1 gene Hepatocellular carcinoma Bioinformatics
Details
Bibliometric analysis of the research hotspots and trends related to Zheng Gan decoction

Published on Frontiers in Pharmaceutical Sciences 2025,29(7):1215-1223.
809 times 111 times

SONG Tianli WANG Yiming LIU Xu XIANG Dehuang HUANG Sheng RAN Yun

Bibliometrics Zheng Gan decoction Hepatocellular carcinoma Anti-tumour Apoptosis
Details